Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 141

1.

Advancing Molecular-Guided Surgery through probe development and testing in a moderate cost evaluation pipeline.

Pogue BW, Paulsen KD, Hull SM, Samkoe KS, Gunn J, Hoopes J, Roberts DW, Strong TV, Draney D, Feldwisch J.

Proc SPIE Int Soc Opt Eng. 2015 Mar 4;9311. pii: 931112.

2.

Nodal lymph flow quantified with afferent vessel input function allows differentiation between normal and cancer-bearing nodes.

DSouza AV, Elliott JT, Gunn JR, Barth RJ Jr, Samkoe KS, Tichauer KM, Pogue BW.

Biomed Opt Express. 2015 Mar 17;6(4):1304-17. doi: 10.1364/BOE.6.001304. eCollection 2015 Apr 1.

3.

Next-generation Raman tomography instrument for non-invasive in vivo bone imaging.

Demers JL, Esmonde-White FW, Esmonde-White KA, Morris MD, Pogue BW.

Biomed Opt Express. 2015 Feb 11;6(3):793-806. doi: 10.1364/BOE.6.000793. eCollection 2015 Mar 1.

4.

Comparison of Kinetic Models for Dual-Tracer Receptor Concentration Imaging in Tumors.

Hamzei N, Samkoe KS, Elliott JT, Holt RW, Gunn JR, Hasan T, Pogue BW, Tichauer KM.

Austin J Biomed Eng. 2014 Mar 5;1(1). pii: austinpublishinggroup.com/biomedical-engineering/fulltext/ajbe-v1-id1002.php.

5.

Sensitivity of MRI-guided near-infrared spectroscopy clinical breast exam data and its impact on diagnostic performance.

Mastanduno MA, Xu J, El-Ghussein F, Jiang S, Yin H, Zhao Y, Michaelsen KE, Wang K, Ren F, Pogue BW, Paulsen KD.

Biomed Opt Express. 2014 Aug 22;5(9):3103-15. doi: 10.1364/BOE.5.003103. eCollection 2014 Sep 1.

6.

Sub-diffusive scattering parameter maps recovered using wide-field high-frequency structured light imaging.

Kanick SC, McClatchy DM 3rd, Krishnaswamy V, Elliott JT, Paulsen KD, Pogue BW.

Biomed Opt Express. 2014 Sep 3;5(10):3376-90. doi: 10.1364/BOE.5.003376. eCollection 2014 Oct 1.

7.

Pixel-based absorption correction for dual-tracer fluorescence imaging of receptor binding potential.

Kanick SC, Tichauer KM, Gunn J, Samkoe KS, Pogue BW.

Biomed Opt Express. 2014 Aug 29;5(10):3280-91. doi: 10.1364/BOE.5.003280. eCollection 2014 Oct 1.

8.

Microscopic lymph node tumor burden quantified by macroscopic dual-tracer molecular imaging.

Tichauer KM, Samkoe KS, Gunn JR, Kanick SC, Hoopes PJ, Barth RJ, Kaufman PA, Hasan T, Pogue BW.

Nat Med. 2014 Nov;20(11):1348-53. doi: 10.1038/nm.3732. Epub 2014 Oct 26.

9.

Video-rate optical dosimetry and dynamic visualization of IMRT and VMAT treatment plans in water using Cherenkov radiation.

Glaser AK, Andreozzi JM, Davis SC, Zhang R, Pogue BW, Fox CJ, Gladstone DJ.

Med Phys. 2014 Jun;41(6):062102. doi: 10.1118/1.4875704.

10.

Impact of treatment response metrics on photodynamic therapy planning and outcomes in a three-dimensional model of ovarian cancer.

Anbil S, Rizvi I, Celli JP, Alagic N, Pogue BW, Hasan T.

J Biomed Opt. 2013 Sep;18(9):098004. doi: 10.1117/1.JBO.18.9.098004.

11.

Accounting for pharmacokinetic differences in dual-tracer receptor density imaging.

Tichauer KM, Diop M, Elliott JT, Samkoe KS, Hasan T, St Lawrence K, Pogue BW.

Phys Med Biol. 2014 May 21;59(10):2341-51. doi: 10.1088/0031-9155/59/10/2341. Epub 2014 Apr 17.

12.

CT contrast predicts pancreatic cancer treatment response to verteporfin-based photodynamic therapy.

Jermyn M, Davis SC, Dehghani H, Huggett MT, Hasan T, Pereira SP, Bown SG, Pogue BW.

Phys Med Biol. 2014 Apr 21;59(8):1911-21. doi: 10.1088/0031-9155/59/8/1911. Epub 2014 Mar 20.

13.

Advances in optics for biotechnology, medicine and surgery.

Fitzmaurice M, Pogue BW, Tearney GJ, Tunnell JW, Yang C.

Biomed Opt Express. 2014 Jan 24;5(2):560-1. doi: 10.1364/BOE.5.000560. eCollection 2014 Feb 1.

14.

Phase I/II study of verteporfin photodynamic therapy in locally advanced pancreatic cancer.

Huggett MT, Jermyn M, Gillams A, Illing R, Mosse S, Novelli M, Kent E, Bown SG, Hasan T, Pogue BW, Pereira SP.

Br J Cancer. 2014 Apr 2;110(7):1698-704. doi: 10.1038/bjc.2014.95. Epub 2014 Feb 25.

15.

Anthropomorphic breast phantoms with physiological water, lipid, and hemoglobin content for near-infrared spectral tomography.

Michaelsen KE, Krishnaswamy V, Shenoy A, Jordan E, Pogue BW, Paulsen KD.

J Biomed Opt. 2014 Feb;19(2):026012. doi: 10.1117/1.JBO.19.2.026012.

16.

An imaging-based platform for high-content, quantitative evaluation of therapeutic response in 3D tumour models.

Celli JP, Rizvi I, Blanden AR, Massodi I, Glidden MD, Pogue BW, Hasan T.

Sci Rep. 2014 Jan 17;4:3751. doi: 10.1038/srep03751.

17.

Direct characterization of arterial input functions by fluorescence imaging of exposed carotid artery to facilitate kinetic analysis.

Elliott JT, Tichauer KM, Samkoe KS, Gunn JR, Sexton KJ, Pogue BW.

Mol Imaging Biol. 2014 Aug;16(4):488-94. doi: 10.1007/s11307-013-0715-y.

18.

Spatial frequency analysis of anisotropic drug transport in tumor samples.

Russell S, Samkoe KS, Gunn JR, Hoopes PJ, Nguyen TA, Russell MJ, Alfano RR, Pogue BW.

J Biomed Opt. 2014 Jan;19(1):15005. doi: 10.1117/1.JBO.19.1.015005.

19.

Contrast enhanced-magnetic resonance imaging as a surrogate to map verteporfin delivery in photodynamic therapy.

Samkoe KS, Bryant A, Gunn JR, Pereira SP, Hasan T, Pogue BW.

J Biomed Opt. 2013 Dec;18(12):120504. doi: 10.1117/1.JBO.18.12.120504.

20.

Topical dual-stain difference imaging for rapid intra-operative tumor identification in fresh specimens.

Davis SC, Gibbs SL, Gunn JR, Pogue BW.

Opt Lett. 2013 Dec 1;38(23):5184-7. doi: 10.1364/OL.38.005184.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk